| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $27.94 ▲ +1.15% | Yesterday | $27.49 ▼ -0.48% | Tomorrow's MapLight Therapeutics Inc. Common Stock (MPLT) setup is anchored to $27.62 and targets $27.94 (+1.15%). The near-term read is upside; watch $28.45 / $26.79 because daily realized volatility is about 5.93%. |
Tomorrow's MapLight Therapeutics Inc. Common Stock (MPLT) setup is anchored to $27.62 and targets $27.94 (+1.15%). The near-term read is upside; watch $28.45 / $26.79 because daily realized volatility is about 5.93%. | ||||
| Week | $28.61 ▲ +3.58% | Last Week | $27.21 ▼ -1.50% | The 7-day MapLight Therapeutics Inc. Common Stock model moves from $27.21 to $28.61 (+3.58%). It gives upside momentum context for this stock, so breaks around $28.45 / $26.79 matter more than a single tick. |
The 7-day MapLight Therapeutics Inc. Common Stock model moves from $27.21 to $28.61 (+3.58%). It gives upside momentum context for this stock, so breaks around $28.45 / $26.79 matter more than a single tick. | ||||
| Month | $29.72 ▲ +7.61% | Last Month | $26.74 ▼ -3.20% | The 1-month MapLight Therapeutics Inc. Common Stock target is $29.72 (+7.61%), compared with the live reference near $27.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month MapLight Therapeutics Inc. Common Stock target is $29.72 (+7.61%), compared with the live reference near $27.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $31.40 ▲ +13.67% | Last Year | $26.03 ▼ -5.74% | The 1-year MapLight Therapeutics Inc. Common Stock scenario points to $31.40 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year MapLight Therapeutics Inc. Common Stock scenario points to $31.40 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $35.31 ▲ +27.86% | 5 Years Ago | $24.39 ▼ -11.70% | The 5-year MapLight Therapeutics Inc. Common Stock view is $35.31 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year MapLight Therapeutics Inc. Common Stock view is $35.31 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $27.62 | Mid |
| Daily Change | -2.54% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 63% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $27.62 | Daily Change | -2.54% |
| Market Cap | $1.17B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.